Similar articles

• Treatment of the insulin resistance syndrome.

  Handelsman Y; FACP, FACE. Handelsman Y, et al. Endocr Pract. 2003 Sep-Oct;9 Suppl 2:99-104. doi: 10.4158/EP.9.S2.99. Endocr Pract. 2003. PMID: 14698987 No abstract available.
• Metabolic syndrome: definition, pathophysiology, and mechanisms.

  Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Miranda PJ, et al. Am Heart J. 2005 Jan;149(1):33-45. doi: 10.1016/j.ahj.2004.07.013. Am Heart J. 2005. PMID: 15660032 No abstract available.
• [Visceral fat syndrome].

  Tokunaga K, Nakamura T, Kubo M, Matsuzawa Y. Tokunaga K, et al. Nihon Naika Gakkai Zasshi. 1992 Nov 10;81(11):1831-5. Nihon Naika Gakkai Zasshi. 1992. PMID: 1479226 Japanese. No abstract available.
• [Metabolic syndrome and lipotoxicity].

  Shimabukuro M. Shimabukuro M. Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1721-5. doi: 10.2169/naika.95.1721. Nihon Naika Gakkai Zasshi. 2006. PMID: 17037305 Review. Japanese. No abstract available.
• Insulin resistance and the metabolic syndrome.

  Lann D, Gallagher E, Leroith D. Lann D, et al. Minerva Med. 2008 Jun;99(3):253-62. Minerva Med. 2008. PMID: 18497723 Review.